Efficacy, Safety, and Immunogenicity of HLX04Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatmentfor Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase IIIStudyShukui Qin, Jiemin Zhao, Jin Li et al.|BioDrugs|2021Cited by 29
Supplementary Figure 1 from Cell Intrinsic Role of COX-2 in Pancreatic Cancer DevelopmentR. J. Hill, Hong Wu, Joseph Hargan Calvopina et al.|Unknown|2023Cited by 0